img

Global Nausea And Vomiting Treatment Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Nausea And Vomiting Treatment Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application

Nausea and Vomiting Treatment also called Antiemetics. Antiemetics included aprepitant, diphenhydramine, granisetron, hydroxyzine, meclizine, ondansetron, prochlorperazine, promethazine, scopolamine, metoclopramide, trimethobenzamide, palonosetron, dolasetron, and thiethylperazine, etc.
Nausea And Vomiting Treatment report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Nausea And Vomiting Treatment market is projected to reach US$ 8115.6 million in 2034, increasing from US$ 5195.5 million in 2022, with the CAGR of 6.5% during the period of 2024 to 2034. Demand from CINV and PONV are the major drivers for the industry.
United States is the largest Nausea And Vomiting Treatment market with about 42% market share. Europe is follower, accounting for about 20% market share.Merck & Co. Inc. was the global greatest company in Nausea And Vomiting Treatment industry, with the market Share of 14% , followed by Helsinn Group, Unimed Pharmaceuticals (AbbVie Inc.), Kyowa Kirin, Sanofi, Qilu Pharma, Teva Pharmaceutical Industries Ltd., Taiji group, Novartis, Heron Therapeutics, Atnahs Pharma UK Limited, Mylan, Duchesnay, Tesaro.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Nausea And Vomiting Treatment market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report



By Company


Merck & Co. Inc.
Helsinn Group
Unimed Pharmaceuticals (AbbVie Inc.)
Kyowa Kirin
Sanofi
Qilu Pharma
Teva Pharmaceutical Industries Ltd.
Taiji group
Novartis
Heron Therapeutics
Pharmanovia
Mylan
Duchesnay
GSK
Segment by Type
Serotonin Receptor Antagonist
Neurokinin NK1 Receptor Antagonist
Others

Segment by Application


CINV
PONV
Motion Sickness
Pregnancy
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries

Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia

Latin America
Mexico
Brazil

Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Nausea And Vomiting Treatment market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2024, 2024-2034).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Nausea And Vomiting Treatment introduction, etc. Nausea And Vomiting Treatment Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12QYResearch’s Conclusions of Nausea And Vomiting Treatment market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by QYResearch.

Table of Content

1 Market Overview of Nausea And Vomiting Treatment
1.1 Nausea And Vomiting Treatment Market Overview
1.1.1 Nausea And Vomiting Treatment Product Scope
1.1.2 Nausea And Vomiting Treatment Market Status and Outlook
1.2 Global Nausea And Vomiting Treatment Market Size Overview by Region 2018 VS 2022 VS 2034
1.3 Global Nausea And Vomiting Treatment Market Size by Region (2018-2034)
1.4 Global Nausea And Vomiting Treatment Historic Market Size by Region (2018-2024)
1.5 Global Nausea And Vomiting Treatment Market Size Forecast by Region (2024-2034)
1.6 Key Regions, Nausea And Vomiting Treatment Market Size (2018-2034)
1.6.1 North America Nausea And Vomiting Treatment Market Size (2018-2034)
1.6.2 Europe Nausea And Vomiting Treatment Market Size (2018-2034)
1.6.3 Asia-Pacific Nausea And Vomiting Treatment Market Size (2018-2034)
1.6.4 Latin America Nausea And Vomiting Treatment Market Size (2018-2034)
1.6.5 Middle East & Africa Nausea And Vomiting Treatment Market Size (2018-2034)
2 Nausea And Vomiting Treatment Market by Type
2.1 Introduction
2.1.1 Serotonin Receptor Antagonist
2.1.2 Neurokinin NK1 Receptor Antagonist
2.1.3 Others
2.2 Global Nausea And Vomiting Treatment Market Size by Type: 2018 VS 2022 VS 2034
2.2.1 Global Nausea And Vomiting Treatment Historic Market Size by Type (2018-2024)
2.2.2 Global Nausea And Vomiting Treatment Forecasted Market Size by Type (2024-2034)
2.3 Key Regions Market Size by Type
2.3.1 North America Nausea And Vomiting Treatment Revenue Breakdown by Type (2018-2034)
2.3.2 Europe Nausea And Vomiting Treatment Revenue Breakdown by Type (2018-2034)
2.3.3 Asia-Pacific Nausea And Vomiting Treatment Revenue Breakdown by Type (2018-2034)
2.3.4 Latin America Nausea And Vomiting Treatment Revenue Breakdown by Type (2018-2034)
2.3.5 Middle East and Africa Nausea And Vomiting Treatment Revenue Breakdown by Type (2018-2034)
3 Nausea And Vomiting Treatment Market Overview by Application
3.1 Introduction
3.1.1 CINV
3.1.2 PONV
3.1.3 Motion Sickness
3.1.4 Pregnancy
3.1.5 Others
3.2 Global Nausea And Vomiting Treatment Market Size by Application: 2018 VS 2022 VS 2034
3.2.1 Global Nausea And Vomiting Treatment Historic Market Size by Application (2018-2024)
3.2.2 Global Nausea And Vomiting Treatment Forecasted Market Size by Application (2024-2034)
3.3 Key Regions Market Size by Application
3.3.1 North America Nausea And Vomiting Treatment Revenue Breakdown by Application (2018-2034)
3.3.2 Europe Nausea And Vomiting Treatment Revenue Breakdown by Application (2018-2034)
3.3.3 Asia-Pacific Nausea And Vomiting Treatment Revenue Breakdown by Application (2018-2034)
3.3.4 Latin America Nausea And Vomiting Treatment Revenue Breakdown by Application (2018-2034)
3.3.5 Middle East and Africa Nausea And Vomiting Treatment Revenue Breakdown by Application (2018-2034)
4 Nausea And Vomiting Treatment Competition Analysis by Players
4.1 Global Nausea And Vomiting Treatment Market Size by Players (2018-2024)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Nausea And Vomiting Treatment as of 2022)
4.3 Date of Key Players Enter into Nausea And Vomiting Treatment Market
4.4 Global Top Players Nausea And Vomiting Treatment Headquarters and Area Served
4.5 Key Players Nausea And Vomiting Treatment Product Solution and Service
4.6 Competitive Status
4.6.1 Nausea And Vomiting Treatment Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Merck & Co. Inc.
5.1.1 Merck & Co. Inc. Profile
5.1.2 Merck & Co. Inc. Main Business
5.1.3 Merck & Co. Inc. Nausea And Vomiting Treatment Products, Services and Solutions
5.1.4 Merck & Co. Inc. Nausea And Vomiting Treatment Revenue (US$ Million) & (2018-2024)
5.1.5 Merck & Co. Inc. Recent Developments
5.2 Helsinn Group
5.2.1 Helsinn Group Profile
5.2.2 Helsinn Group Main Business
5.2.3 Helsinn Group Nausea And Vomiting Treatment Products, Services and Solutions
5.2.4 Helsinn Group Nausea And Vomiting Treatment Revenue (US$ Million) & (2018-2024)
5.2.5 Helsinn Group Recent Developments
5.3 Unimed Pharmaceuticals (AbbVie Inc.)
5.3.1 Unimed Pharmaceuticals (AbbVie Inc.) Profile
5.3.2 Unimed Pharmaceuticals (AbbVie Inc.) Main Business
5.3.3 Unimed Pharmaceuticals (AbbVie Inc.) Nausea And Vomiting Treatment Products, Services and Solutions
5.3.4 Unimed Pharmaceuticals (AbbVie Inc.) Nausea And Vomiting Treatment Revenue (US$ Million) & (2018-2024)
5.3.5 Kyowa Kirin Recent Developments
5.4 Kyowa Kirin
5.4.1 Kyowa Kirin Profile
5.4.2 Kyowa Kirin Main Business
5.4.3 Kyowa Kirin Nausea And Vomiting Treatment Products, Services and Solutions
5.4.4 Kyowa Kirin Nausea And Vomiting Treatment Revenue (US$ Million) & (2018-2024)
5.4.5 Kyowa Kirin Recent Developments
5.5 Sanofi
5.5.1 Sanofi Profile
5.5.2 Sanofi Main Business
5.5.3 Sanofi Nausea And Vomiting Treatment Products, Services and Solutions
5.5.4 Sanofi Nausea And Vomiting Treatment Revenue (US$ Million) & (2018-2024)
5.5.5 Sanofi Recent Developments
5.6 Qilu Pharma
5.6.1 Qilu Pharma Profile
5.6.2 Qilu Pharma Main Business
5.6.3 Qilu Pharma Nausea And Vomiting Treatment Products, Services and Solutions
5.6.4 Qilu Pharma Nausea And Vomiting Treatment Revenue (US$ Million) & (2018-2024)
5.6.5 Qilu Pharma Recent Developments
5.7 Teva Pharmaceutical Industries Ltd.
5.7.1 Teva Pharmaceutical Industries Ltd. Profile
5.7.2 Teva Pharmaceutical Industries Ltd. Main Business
5.7.3 Teva Pharmaceutical Industries Ltd. Nausea And Vomiting Treatment Products, Services and Solutions
5.7.4 Teva Pharmaceutical Industries Ltd. Nausea And Vomiting Treatment Revenue (US$ Million) & (2018-2024)
5.7.5 Teva Pharmaceutical Industries Ltd. Recent Developments
5.8 Taiji group
5.8.1 Taiji group Profile
5.8.2 Taiji group Main Business
5.8.3 Taiji group Nausea And Vomiting Treatment Products, Services and Solutions
5.8.4 Taiji group Nausea And Vomiting Treatment Revenue (US$ Million) & (2018-2024)
5.8.5 Taiji group Recent Developments
5.9 Novartis
5.9.1 Novartis Profile
5.9.2 Novartis Main Business
5.9.3 Novartis Nausea And Vomiting Treatment Products, Services and Solutions
5.9.4 Novartis Nausea And Vomiting Treatment Revenue (US$ Million) & (2018-2024)
5.9.5 Novartis Recent Developments
5.10 Heron Therapeutics
5.10.1 Heron Therapeutics Profile
5.10.2 Heron Therapeutics Main Business
5.10.3 Heron Therapeutics Nausea And Vomiting Treatment Products, Services and Solutions
5.10.4 Heron Therapeutics Nausea And Vomiting Treatment Revenue (US$ Million) & (2018-2024)
5.10.5 Heron Therapeutics Recent Developments
5.11 Pharmanovia
5.11.1 Pharmanovia Profile
5.11.2 Pharmanovia Main Business
5.11.3 Pharmanovia Nausea And Vomiting Treatment Products, Services and Solutions
5.11.4 Pharmanovia Nausea And Vomiting Treatment Revenue (US$ Million) & (2018-2024)
5.11.5 Pharmanovia Recent Developments
5.12 Mylan
5.12.1 Mylan Profile
5.12.2 Mylan Main Business
5.12.3 Mylan Nausea And Vomiting Treatment Products, Services and Solutions
5.12.4 Mylan Nausea And Vomiting Treatment Revenue (US$ Million) & (2018-2024)
5.12.5 Mylan Recent Developments
5.13 Duchesnay
5.13.1 Duchesnay Profile
5.13.2 Duchesnay Main Business
5.13.3 Duchesnay Nausea And Vomiting Treatment Products, Services and Solutions
5.13.4 Duchesnay Nausea And Vomiting Treatment Revenue (US$ Million) & (2018-2024)
5.13.5 Duchesnay Recent Developments
5.14 GSK
5.14.1 GSK Profile
5.14.2 GSK Main Business
5.14.3 GSK Nausea And Vomiting Treatment Products, Services and Solutions
5.14.4 GSK Nausea And Vomiting Treatment Revenue (US$ Million) & (2018-2024)
5.14.5 GSK Recent Developments
6 North America
6.1 North America Nausea And Vomiting Treatment Market Size by Country (2018-2034)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Nausea And Vomiting Treatment Market Size by Country (2018-2034)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Nausea And Vomiting Treatment Market Size by Region (2018-2034)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Nausea And Vomiting Treatment Market Size by Country (2018-2034)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Nausea And Vomiting Treatment Market Size by Country (2018-2034)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Nausea And Vomiting Treatment Market Dynamics
11.1 Nausea And Vomiting Treatment Industry Trends
11.2 Nausea And Vomiting Treatment Market Drivers
11.3 Nausea And Vomiting Treatment Market Challenges
11.4 Nausea And Vomiting Treatment Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

List of Figure

List of Tables
Table 1. Global Market Nausea And Vomiting Treatment Market Size (US$ Million) Comparison by Region 2018 VS 2022 VS 2034
Table 2. Global Nausea And Vomiting Treatment Market Size by Region (2018-2024) & (US$ Million)
Table 3. Global Nausea And Vomiting Treatment Market Size Share by Region (2018-2024)
Table 4. Global Nausea And Vomiting Treatment Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 5. Global Nausea And Vomiting Treatment Forecasted Market Size Share by Region (2024-2034)
Table 6. Global Nausea And Vomiting Treatment Market Size (US$ Million) by Type: 2018 VS 2022 VS 2034
Table 7. Global Nausea And Vomiting Treatment Market Size by Type (2018-2024) & (US$ Million)
Table 8. Global Nausea And Vomiting Treatment Revenue Market Share by Type (2018-2024)
Table 9. Global Nausea And Vomiting Treatment Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 10. Global Nausea And Vomiting Treatment Revenue Market Share by Type (2024-2034)
Table 11. North America Nausea And Vomiting Treatment Revenue by Type (2018-2024) & (US$ Million)
Table 12. North America Nausea And Vomiting Treatment Revenue by Type (2024-2034) & (US$ Million)
Table 13. Europe Nausea And Vomiting Treatment Revenue by Type (2018-2024) & (US$ Million)
Table 14. Europe Nausea And Vomiting Treatment Revenue by Type (2024-2034) & (US$ Million)
Table 15. Asia-Pacific Nausea And Vomiting Treatment Revenue by Type (2018-2024) & (US$ Million)
Table 16. Asia-Pacific Nausea And Vomiting Treatment Revenue by Type (2024-2034) & (US$ Million)
Table 17. Latin America Nausea And Vomiting Treatment Revenue by Type (2018-2024) & (US$ Million)
Table 18. Latin America Nausea And Vomiting Treatment Revenue by Type (2024-2034) & (US$ Million)
Table 19. Middle East and Africa Nausea And Vomiting Treatment Revenue by Type (2018-2024) & (US$ Million)
Table 20. Middle East and Africa Nausea And Vomiting Treatment Revenue by Type (2024-2034) & (US$ Million)
Table 21. Global Nausea And Vomiting Treatment Market Size (US$ Million) by Application: 2018 VS 2022 VS 2034
Table 22. Global Nausea And Vomiting Treatment Market Size by Application (2018-2024) & (US$ Million)
Table 23. Global Nausea And Vomiting Treatment Revenue Market Share by Application (2018-2024)
Table 24. Global Nausea And Vomiting Treatment Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 25. Global Nausea And Vomiting Treatment Revenue Market Share by Application (2024-2034)
Table 26. North America Nausea And Vomiting Treatment Revenue by Application (2018-2024) & (US$ Million)
Table 27. North America Nausea And Vomiting Treatment Revenue by Application (2024-2034) & (US$ Million)
Table 28. Europe Nausea And Vomiting Treatment Revenue by Application (2018-2024) & (US$ Million)
Table 29. Europe Nausea And Vomiting Treatment Revenue by Application (2024-2034) & (US$ Million)
Table 30. Asia-Pacific Nausea And Vomiting Treatment Revenue by Application (2018-2024) & (US$ Million)
Table 31. Asia-Pacific Nausea And Vomiting Treatment Revenue by Application (2024-2034) & (US$ Million)
Table 32. Latin America Nausea And Vomiting Treatment Revenue by Application (2018-2024) & (US$ Million)
Table 33. Latin America Nausea And Vomiting Treatment Revenue by Application (2024-2034) & (US$ Million)
Table 34. Middle East and Africa Nausea And Vomiting Treatment Revenue by Application (2018-2024) & (US$ Million)
Table 35. Middle East and Africa Nausea And Vomiting Treatment Revenue by Application (2024-2034) & (US$ Million)
Table 36. Global Nausea And Vomiting Treatment Revenue (US$ Million) by Players (2018-2024)
Table 37. Global Nausea And Vomiting Treatment Revenue Market Share by Players (2018-2024)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Nausea And Vomiting Treatment as of 2022)
Table 39. Date of Key Players Enter into Nausea And Vomiting Treatment Market
Table 40. Global Nausea And Vomiting Treatment Key Players Headquarters and Area Served
Table 41. Nausea And Vomiting Treatment Product Solution and Service
Table 42. Global Nausea And Vomiting Treatment Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. Merck & Co. Inc. Basic Information List
Table 45. Merck & Co. Inc. Description and Business Overview
Table 46. Merck & Co. Inc. Nausea And Vomiting Treatment Products, Services and Solutions
Table 47. Revenue (US$ Million) in Nausea And Vomiting Treatment Business of Merck & Co. Inc. (2018-2024)
Table 48. Merck & Co. Inc. Recent Developments
Table 49. Helsinn Group Basic Information List
Table 50. Helsinn Group Description and Business Overview
Table 51. Helsinn Group Nausea And Vomiting Treatment Products, Services and Solutions
Table 52. Revenue (US$ Million) in Nausea And Vomiting Treatment Business of Helsinn Group (2018-2024)
Table 53. Helsinn Group Recent Developments
Table 54. Unimed Pharmaceuticals (AbbVie Inc.) Basic Information List
Table 55. Unimed Pharmaceuticals (AbbVie Inc.) Description and Business Overview
Table 56. Unimed Pharmaceuticals (AbbVie Inc.) Nausea And Vomiting Treatment Products, Services and Solutions
Table 57. Revenue (US$ Million) in Nausea And Vomiting Treatment Business of Unimed Pharmaceuticals (AbbVie Inc.) (2018-2024)
Table 58. Unimed Pharmaceuticals (AbbVie Inc.) Recent Developments
Table 59. Kyowa Kirin Basic Information List
Table 60. Kyowa Kirin Description and Business Overview
Table 61. Kyowa Kirin Nausea And Vomiting Treatment Products, Services and Solutions
Table 62. Revenue (US$ Million) in Nausea And Vomiting Treatment Business of Kyowa Kirin (2018-2024)
Table 63. Kyowa Kirin Recent Developments
Table 64. Sanofi Basic Information List
Table 65. Sanofi Description and Business Overview
Table 66. Sanofi Nausea And Vomiting Treatment Products, Services and Solutions
Table 67. Revenue (US$ Million) in Nausea And Vomiting Treatment Business of Sanofi (2018-2024)
Table 68. Sanofi Recent Developments
Table 69. Qilu Pharma Basic Information List
Table 70. Qilu Pharma Description and Business Overview
Table 71. Qilu Pharma Nausea And Vomiting Treatment Products, Services and Solutions
Table 72. Revenue (US$ Million) in Nausea And Vomiting Treatment Business of Qilu Pharma (2018-2024)
Table 73. Qilu Pharma Recent Developments
Table 74. Teva Pharmaceutical Industries Ltd. Basic Information List
Table 75. Teva Pharmaceutical Industries Ltd. Description and Business Overview
Table 76. Teva Pharmaceutical Industries Ltd. Nausea And Vomiting Treatment Products, Services and Solutions
Table 77. Revenue (US$ Million) in Nausea And Vomiting Treatment Business of Teva Pharmaceutical Industries Ltd. (2018-2024)
Table 78. Teva Pharmaceutical Industries Ltd. Recent Developments
Table 79. Taiji group Basic Information List
Table 80. Taiji group Description and Business Overview
Table 81. Taiji group Nausea And Vomiting Treatment Products, Services and Solutions
Table 82. Revenue (US$ Million) in Nausea And Vomiting Treatment Business of Taiji group (2018-2024)
Table 83. Taiji group Recent Developments
Table 84. Novartis Basic Information List
Table 85. Novartis Description and Business Overview
Table 86. Novartis Nausea And Vomiting Treatment Products, Services and Solutions
Table 87. Revenue (US$ Million) in Nausea And Vomiting Treatment Business of Novartis (2018-2024)
Table 88. Novartis Recent Developments
Table 89. Heron Therapeutics Basic Information List
Table 90. Heron Therapeutics Description and Business Overview
Table 91. Heron Therapeutics Nausea And Vomiting Treatment Products, Services and Solutions
Table 92. Revenue (US$ Million) in Nausea And Vomiting Treatment Business of Heron Therapeutics (2018-2024)
Table 93. Heron Therapeutics Recent Developments
Table 94. Pharmanovia Basic Information List
Table 95. Pharmanovia Description and Business Overview
Table 96. Pharmanovia Nausea And Vomiting Treatment Products, Services and Solutions
Table 97. Revenue (US$ Million) in Nausea And Vomiting Treatment Business of Pharmanovia (2018-2024)
Table 98. Pharmanovia Recent Developments
Table 99. Mylan Basic Information List
Table 100. Mylan Description and Business Overview
Table 101. Mylan Nausea And Vomiting Treatment Products, Services and Solutions
Table 102. Revenue (US$ Million) in Nausea And Vomiting Treatment Business of Mylan (2018-2024)
Table 103. Mylan Recent Developments
Table 104. Duchesnay Basic Information List
Table 105. Duchesnay Description and Business Overview
Table 106. Duchesnay Nausea And Vomiting Treatment Products, Services and Solutions
Table 107. Revenue (US$ Million) in Nausea And Vomiting Treatment Business of Duchesnay (2018-2024)
Table 108. Duchesnay Recent Developments
Table 109. GSK Basic Information List
Table 110. GSK Description and Business Overview
Table 111. GSK Nausea And Vomiting Treatment Products, Services and Solutions
Table 112. Revenue (US$ Million) in Nausea And Vomiting Treatment Business of GSK (2018-2024)
Table 113. GSK Recent Developments
Table 114. North America Nausea And Vomiting Treatment Market Size by Country (2018-2024) & (US$ Million)
Table 115. North America Nausea And Vomiting Treatment Market Size by Country (2024-2034) & (US$ Million)
Table 116. Europe Nausea And Vomiting Treatment Market Size by Country (2018-2024) & (US$ Million)
Table 117. Europe Nausea And Vomiting Treatment Market Size by Country (2024-2034) & (US$ Million)
Table 118. Asia-Pacific Nausea And Vomiting Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2034
Table 119. Asia-Pacific Nausea And Vomiting Treatment Market Size by Region (2018-2024) & (US$ Million)
Table 120. Asia-Pacific Nausea And Vomiting Treatment Market Size by Region (2024-2034) & (US$ Million)
Table 121. Asia-Pacific Nausea And Vomiting Treatment Market Share by Region (2018-2024)
Table 122. Asia-Pacific Nausea And Vomiting Treatment Market Share by Region (2024-2034)
Table 123. Latin America Nausea And Vomiting Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2034
Table 124. Latin America Nausea And Vomiting Treatment Market Size by Country (2018-2024) & (US$ Million)
Table 125. Latin America Nausea And Vomiting Treatment Market Size by Country (2024-2034) & (US$ Million)
Table 126. Middle East & Africa Nausea And Vomiting Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2034
Table 127. Middle East & Africa Nausea And Vomiting Treatment Market Size by Country (2018-2024) & (US$ Million)
Table 128. Middle East & Africa Nausea And Vomiting Treatment Market Size by Country (2024-2034) & (US$ Million)
Table 129. Nausea And Vomiting Treatment Market Trends
Table 130. Nausea And Vomiting Treatment Market Drivers
Table 131. Nausea And Vomiting Treatment Market Challenges
Table 132. Nausea And Vomiting Treatment Market Restraints
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Nausea And Vomiting Treatment Market Size Year-over-Year 2018-2034 & (US$ Million)
Figure 2. Global Nausea And Vomiting Treatment Market Size (US$ Million), 2018 VS 2022 VS 2034
Figure 3. Global Nausea And Vomiting Treatment Market Share by Regions: 2022 VS 2034
Figure 4. Global Nausea And Vomiting Treatment Forecasted Market Size Share by Region (2024-2034)
Figure 5. North America Nausea And Vomiting Treatment Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 6. Europe Nausea And Vomiting Treatment Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 7. Asia-Pacific Nausea And Vomiting Treatment Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 8. Latin America Nausea And Vomiting Treatment Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 9. Middle East & Africa Nausea And Vomiting Treatment Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 10. Product Picture of Serotonin Receptor Antagonist
Figure 11. Global Serotonin Receptor Antagonist Market Size (US$ Million) & YoY Growth (2018-2034)
Figure 12. Product Picture of Neurokinin NK1 Receptor Antagonist
Figure 13. Global Neurokinin NK1 Receptor Antagonist Market Size (US$ Million) & YoY Growth (2018-2034)
Figure 14. Product Picture of Others
Figure 15. Global Others Market Size (US$ Million) & YoY Growth (2018-2034)
Figure 16. Global Nausea And Vomiting Treatment Market Size Share by Type: 2022 & 2034
Figure 17. North America Nausea And Vomiting Treatment Revenue Market Share by Type (2018-2034)
Figure 18. Europe Nausea And Vomiting Treatment Revenue Market Share by Type (2018-2034)
Figure 19. Asia-Pacific Nausea And Vomiting Treatment Revenue Market Share by Type (2018-2034)
Figure 20. Latin America Nausea And Vomiting Treatment Revenue Market Share by Type (2018-2034)
Figure 21. Middle East and Africa Nausea And Vomiting Treatment Revenue Market Share by Type (2018-2034)
Figure 22. CINV Market Size (US$ Million) & YoY Growth (2018-2034)
Figure 23. PONV Market Size (US$ Million) & YoY Growth (2018-2034)
Figure 24. Motion Sickness Market Size (US$ Million) & YoY Growth (2018-2034)
Figure 25. Pregnancy Market Size (US$ Million) & YoY Growth (2018-2034)
Figure 26. Others Market Size (US$ Million) & YoY Growth (2018-2034)
Figure 27. Global Nausea And Vomiting Treatment Market Size Share by Application: 2022 & 2034
Figure 28. North America Nausea And Vomiting Treatment Revenue Market Share by Application (2018-2034)
Figure 29. Europe Nausea And Vomiting Treatment Revenue Market Share by Application (2018-2034)
Figure 30. Asia-Pacific Nausea And Vomiting Treatment Revenue Market Share by Application (2018-2034)
Figure 31. Latin America Nausea And Vomiting Treatment Revenue Market Share by Application (2018-2034)
Figure 32. Middle East and Africa Nausea And Vomiting Treatment Revenue Market Share by Application (2018-2034)
Figure 33. Nausea And Vomiting Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 34. Global Top 5 and Top 10 Players Nausea And Vomiting Treatment Market Share in 2022
Figure 35. North America Nausea And Vomiting Treatment Market Share by Country (2018-2034)
Figure 36. U.S. Nausea And Vomiting Treatment Market Size (2018-2034) & (US$ Million)
Figure 37. Canada Nausea And Vomiting Treatment Market Size (2018-2034) & (US$ Million)
Figure 38. Germany Nausea And Vomiting Treatment Market Size (2018-2034) & (US$ Million)
Figure 39. France Nausea And Vomiting Treatment Market Size (2018-2034) & (US$ Million)
Figure 40. U.K. Nausea And Vomiting Treatment Market Size (2018-2034) & (US$ Million)
Figure 41. Italy Nausea And Vomiting Treatment Market Size (2018-2034) & (US$ Million)
Figure 42. Russia Nausea And Vomiting Treatment Market Size (2018-2034) & (US$ Million)
Figure 43. Nordic Countries Nausea And Vomiting Treatment Market Size (2018-2034) & (US$ Million)
Figure 44. Asia-Pacific Nausea And Vomiting Treatment Market Share by Region (2018-2034)
Figure 45. China Nausea And Vomiting Treatment Market Size (2018-2034) & (US$ Million)
Figure 46. Japan Nausea And Vomiting Treatment Market Size (2018-2034) & (US$ Million)
Figure 47. South Korea Nausea And Vomiting Treatment Market Size (2018-2034) & (US$ Million)
Figure 48. Southeast Asia Nausea And Vomiting Treatment Market Size (2018-2034) & (US$ Million)
Figure 49. India Nausea And Vomiting Treatment Market Size (2018-2034) & (US$ Million)
Figure 50. Australia Nausea And Vomiting Treatment Market Size (2018-2034) & (US$ Million)
Figure 51. Latin America Nausea And Vomiting Treatment Market Share by Country (2018-2034)
Figure 52. Mexico Nausea And Vomiting Treatment Market Size (2018-2034) & (US$ Million)
Figure 53. Brazil Nausea And Vomiting Treatment Market Size (2018-2034) & (US$ Million)
Figure 54. Middle East & Africa Nausea And Vomiting Treatment Market Share by Country (2018-2034)
Figure 55. Turkey Nausea And Vomiting Treatment Market Size (2018-2034) & (US$ Million)
Figure 56. Saudi Arabia Nausea And Vomiting Treatment Market Size (2018-2034) & (US$ Million)
Figure 57. UAE Nausea And Vomiting Treatment Market Size (2018-2034) & (US$ Million)
Figure 58. Bottom-up and Top-down Approaches for This Report